Prognosis for patients with critical lg ischemia is often poor, and no pharmacotherapy has been effective. In this issue, the ICAI Study Group reports that prostaglandin E1 used to treat this condition had initial benefits that disappeared with time. Another potential medical approach to critical leg ischemia that has shown early promise is the use of gene transfer to repair the vascular system.